147 related articles for article (PubMed ID: 16961440)
21. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D
Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
[TBL] [Abstract][Full Text] [Related]
22. Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes.
Zhang Q; Safford M; Miller D; Crystal S; Rajan M; Tseng CL; Pogach L
Med Care; 2007 Apr; 45(4):308-14. PubMed ID: 17496714
[TBL] [Abstract][Full Text] [Related]
23. Long-term persistence with statin therapy: a nationwide register study in Finland.
Helin-Salmivaara A; Lavikainen P; Korhonen MJ; Halava H; Junnila SY; Kettunen R; Neuvonen PJ; Martikainen JE; Ruokoniemi P; Saastamoinen LK; Virta L; Huupponen R
Clin Ther; 2008; 30 Pt 2():2228-40. PubMed ID: 19281917
[TBL] [Abstract][Full Text] [Related]
24. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
[TBL] [Abstract][Full Text] [Related]
25. Effect of a medication copayment increase in veterans with schizophrenia.
Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
[TBL] [Abstract][Full Text] [Related]
26. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
27. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
28. The effects of copayments on medication adherence during the first two years of prescription drug treatment.
Kessler RC; Cantrell CR; Berglund P; Sokol MC
J Occup Environ Med; 2007 Jun; 49(6):597-609. PubMed ID: 17563602
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
Mullins CD; Rattinger GB; Kuznik A; Koren MJ
Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
[TBL] [Abstract][Full Text] [Related]
30. The effects of prescription drug cost sharing: a review of the evidence.
Gibson TB; Ozminkowski RJ; Goetzel RZ
Am J Manag Care; 2005 Nov; 11(11):730-40. PubMed ID: 16268755
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
[TBL] [Abstract][Full Text] [Related]
32. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
Kalsekar I; Sheehan C; Peak A
Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
[TBL] [Abstract][Full Text] [Related]
33. Effect of patient medication cost share on adherence and glycemic control.
Hunt J; Rozenfeld Y; Shenolikar R
Manag Care; 2009 Jul; 18(7):47-53. PubMed ID: 19639897
[TBL] [Abstract][Full Text] [Related]
34. Factors contributing to compliance with osteoporosis medication.
Kertes J; Dushenat M; Vesterman JL; Lemberger J; Bregman J; Friedman N
Isr Med Assoc J; 2008 Mar; 10(3):207-13. PubMed ID: 18494234
[TBL] [Abstract][Full Text] [Related]
35. Consumer response to dual incentives under multitiered prescription drug formularies.
Gilman BH; Kautter J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
[TBL] [Abstract][Full Text] [Related]
36. Factors related to adherence to statin therapy.
McGinnis B; Olson KL; Magid D; Bayliss E; Korner EJ; Brand DW; Steiner JF
Ann Pharmacother; 2007 Nov; 41(11):1805-11. PubMed ID: 17925498
[TBL] [Abstract][Full Text] [Related]
37. The effect of a large regional health plan's value-based insurance design program on statin use.
Frank MB; Fendrick AM; He Y; Zbrozek A; Holtz N; Leung S; Chernew ME
Med Care; 2012 Nov; 50(11):934-9. PubMed ID: 23047782
[TBL] [Abstract][Full Text] [Related]
38. Adherence with statins over 8 years in a usual care setting.
Vinker S; Shani M; Baevsky T; Elhayany A
Am J Manag Care; 2008 Jun; 14(6):388-92. PubMed ID: 18554077
[TBL] [Abstract][Full Text] [Related]
39. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.
Landsman PB; Yu W; Liu X; Teutsch SM; Berger ML
Am J Manag Care; 2005 Oct; 11(10):621-8. PubMed ID: 16232003
[TBL] [Abstract][Full Text] [Related]
40. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
Watanabe JH; Kazerooni R; Bounthavong M
J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
